Clinical results with catheter ablation: AV junction, atrial fibrillation and ventricular tachycardia.
With the limitations of pharmacologic and device therapies for atrial fibrillation and ventricular tachycardia, catheter ablation is assuming a larger role in the management of patients with these common arrhythmias. Multiple case series and clinical trials have helped to define the evolving role of these techniques for ablation of the atrioventricular node, atrial fibrillation, and ischemic ventricular tachycardia. Based on very low complication rates, excellent efficacy and proven outcomes with radiofrequency ablation of the atrioventricular node, this approach with permanent pacing should play a larger role in the treatment of symptomatic patients with permanent atrial fibrillation. While linear ablation of atrial fibrillation has limited clinical utility for the treatment of this common arrhythmia, the results of multiple case series of focal atrial fibrillation ablation indicate the potential for an expanding role of this curative technique. Catheter ablation techniques for ventricular tachycardia in the setting of coronary artery disease have a role as supplemental therapy to the implantable cardioverter defibrillator in patients with recurrent pharmacologically refractory ventricular arrhythmias requiring frequent device interventions.
Cardiac Arrhythmia Center, Division of Cardiology, Department of Medicine, Tufts University School of Medicine, Tufts-New England Medical Center, 750 Washington Street, Boston, MA 02111, USA.
Jonathan
J
Weinstock
Paul J
PJ
Wang
Munther K
MK
Homoud
Mark S
MS
Link
N A Mark
NA
Estes
D001281:Atrial Fibrillation / Q000601:surgery; D001283:Atrioventricular Node / Q000473:pathology / Q000601:surgery; D017115:Catheter Ablation; D002986:Clinical Trials as Topic; D006801:Humans; D011667:Pulmonary Veins / Q000601:surgery; D017180:Tachycardia, Ventricular / Q000601:surgery; D016896:Treatment Outcome